In vitro evaluation of antiproliferative potential of calcium channel blockers in human Tenon's fibroblasts

Experimental Eye Research

Volumn 64, Issue 6, 1997, Pages 913-925

  Kang, Yoosang ^a   Lee, David A ^a   Higginbotham, Eve J ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

Antiproliferative effects; Calcium channel blockers; Fibroblast proliferation; Glaucoma filtration surgery; Tissue culture

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; CALCIUM; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CYCLIC AMP; DANTROLENE; DILTIAZEM; FLUOROURACIL; MITOMYCIN C; NICARDIPINE; PROTEIN KINASE C; THROMBOXANE; TRIFLUOPERAZINE; VERAPAMIL;

ARTICLE; CATALYSIS; CELL CULTURE; CELL DENSITY; CELL PROLIFERATION; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TISSUE INJURY; WOUND HEALING;

EID: 0031171891     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1997.0285     Document Type: Article

References (59)

1. Abelson, M. B. Gilbert, C. M. Smith, L. M. (1988), Sustained reduction of intraocular pressure in humans with the calcium channel blocker verapamil. Am. J. Ophthalmol. 105, 155, 9.
2. Addicks, E. M. Quigley, H. A. Green, W. R. Robin, A. L. (1983), Histologic characteristics of filtering blebs in glaucomatous eyes. Arch. Ophthalmol. 101, 795.
3. Andrawis, N. S. Abernethy, D. R. (1993), Effect of calcium antagonists on RNA synthesis of NIH 3T3 cells. Am. J. Med. Sci. 306, 137, 40.
4. Batra, S. Popper, L. D. Hartley-Asp, B. (1991), Effect of calcium and calcium antagonists on 45Ca influx and cellular growth of human prostatic tumor cells. Prostate, 19, 299, 311.
5. 2+, Proc. Natl Acad. Sci. U.S.A. 86, 2388, 92.
6. 2+, Proc. Natl. Acad. Sci. U.S.A. 88, 9041, 5.
7. Bonadonna, G. (1986), Verapamil inhibits platelet aggregation by a calcium-independent mechanism. Thrombosis and Haemostasis, 56, 308, 10.
8. 2+, Asaio Transactions, 35, 418, 20.
9. Carter, C. J. Brooks, D. E. Doyle, D. L. Drance, S. M. (1990), Investigations into a vascular etiology for low-tension glaucoma. Ophthalmology, 97, 49, 55.
10. Cutie, M. R. (1993), Compatibility of verapamil hydrochloride injection with commonly used additives. Am. J. Hos. Pharm. 40, 1205, 7.
11. el-Sanadiki, M. N. Cross, K. S. Murray, J. J. Schuman, R. W. Mikat, E. McCann, R. L. Hagen, P. O. (1990), Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment. Annals Surg. 212, 87, 96.
12. Estacion, M. Mordan, L. J. (1993), Competence induction by PDGF requires sustained calcium influx by a mechanism distinct from storage-dependent calcium influx. Cell Calcium, 14, 439, 54.
13. Finney, D. J. 1978), Quantal responses and the tolerance distribution. Statistical method in biological assay. 349, 69, Charles Griffin, London.
14. Freissmuth, M. Gilman, A. G. (1991), G proteins and the regulation of second messenger systems. Harrison's principles of internal medicine. Wilson, J. D.Braunwald, E.Isselbacher, K. J.Petersdorf, R. G.Martin, J. B.Fauci, A. S.Root, R. K.). 348, 53, McGraw-Hill, New York.
15. Glusa, E. (1988), Effect of verapamil on platelet aggregation. Folia Hematol. 115, 469, 73.
16. Goyal, J. K. Khilnani, G. Sharma, D. P. Singh, J. 1989, The hypotensive effect of verapamil eye drops on ocular hypertension. Jnl. J. Ophthalmol. 37, 176, 8.
17. Green, K. Kim, K. 1977, Papaverine and verapamil interaction with prostaglandin E2 and delta 9-tetrahydrocannabinol in the eye. Exp. Eye Res. 24, 207, 12.
18. Gressel, M. G. Parrish, R. K. II, Folberg, R. (1984), 5-Fluorouracil and glaucoma filtering surgery: I. An animal model. Ophthalmology, 91, 378.
19. Grierson, I. Joseph, J. Miller, M. Day, J. E. (1988), Wound repair: The fibroblast and the inhibitor of scar formation. Eye, 2, 135.
20. Handin, R. I. (1991), Bleeding and thrombosis. Harrison's principles of internal medicine. Wilson, J. D.Braunwald, E.Isselbacher, K. J.Petersdorf, R. G.Martin, J. B.Fauci, A. S.Root, R. K.). 348, 53, McGraw-Hill, New York.
21. Iakushkin, V. V. Tertov, V. V. Orekhov, A. N. (1993), The antiatherosclerotic effect of verapamil in a cell culture of human aortic intima. Kardiologiia, 33, 51, 5.
22. Kaneko, T. Nagata, I. Kikuchi, H. Miyamoto, S. Kubo, H. Fujisato, T. Ikada, Y. (1992), The effect of nicardipine on angiogenesis in vitro. Archiv fur Japanische Chirurgie, 61, 150, 5.
23. Kazlauskas, A. Bowen-Pope, D. Seifert, R. Hart, C. E. Cooper, J. A. (1988), Different effects of homo- and heterodimers of platelet-derived growth factor A and B chains on human and mouse fibroblasts. EMBO J. 7, 3727, 35.
24. Knezevic, I. Dieter, J. P. Le Breton, G. C. (1991), Mechanism of inositol 1,4,5-triphosphate-induced aggregation in saponin-permeabilized platelets. J. Pharmacol. Exp. Ther. 260, 947, 55.
25. Koy, Y. D. Sachinidis, A. Graack, G. H. Appenheimer, M. Wieczorek, A. J. Dusing, R. Vetter, H. (1992), Inhibition of angiotensin II and platelet-derived growth factor-induced vascular smooth muscle cell proliferation by calcium entry blockers. Clin. Invest. 70, 113, 7.
26. Landegren, U. (1984), Measurement of cell numbers by means of the endogenous enzyme hexosaminidase: applications to detection of lymphokines and cell surface antigens. J. Immunol. Methods, 67, 379.
27. Lee, D. A. Hersh, P. Kersten, D. Melamed, S. (1987), Complications of subconjunctival 5-fluorouracil following glaucoma filtering surgery. Ophthalmic Surg. 18, 187.
28. Lee, D. A. Leong, K. W. Panek, W. C. Eng, C. T. Glasgow, B. J. (1988), The use of bioerodible polymers and 5-fluorouracil in glaucoma filtering surgery. Invest. Ophthalmol. Vis. Sci. 29, 1692.
29. Lee, R. C. Ping, J. (1990), Calcium antagonists retard extracellular matrix production in connective tissue equivalent. J. Surg. Res. 49, 463, 6.
30. Long, J. W. Rybacki, J. J. (1994), The essential guide to prescription drugs. Long, J. W.Rybacki, J. J. 439-41, 754-8, 1030-4, 1043, 7, Harper Perennial, New York.
31. Lundstrom, T. Ryden, L. (1990), Ventricular rate control and exercise performance in chronic atrial fibrillation: Effects of diltiazem and verapamil. J. Am. Coll. Cardiol. 16, 86, 90.
32. MacNeil, S. Dawson, R. A. Crocker, G. Tucker, W. F. Bittiner, B. Singleton, J. G. Hunter, T. Tierney, D. F. (1993), Antiproliferative effects of keratinocytes of a range of clinically used drugs with calmodulin antagonist activity. Brit. J. Dermatol. 128, 143, 50.
33. Malaterre, H. R. Lauribe, P. Paganelli, F. Ramond, B. Levy, S. (1992), Parkinson syndrome, a possible adverse effect of calcium inhibitors. Archives des Maladies du Coeur et des Vaisseaux, 85, 1335, 7.
34. Mallat, A. Preaux, A. Blazejewski, S. Dhumeaux, D. Rosenbaum, J. Mavier, P. (1994), Effect of simvastatin, an inhibitor of hydroxy-methylglutaryl coenzyme A reductase, on the growth of human Ito cells. Hepatology, 20, 1589, 94.
35. Malmgren, R. (1986), ATP-secretion occurs as an initial response in collagen induced platelet activation. Thromb. Res. 43, 445, 53.
36. Maltese, W. A. (1990), Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J. 4, 3319, 28.
37. Means, A. R. VanBerkum, M. F. A. Bagchi, I. Lu, K. P. Rasmussen, C. D. (1991), Regulatory functions of calmodulin. Pharmac. Ther. 50, 255, 70.
38. MacManus, J. P. Boynton, A. L. Whitfield, J. F. (1982), The role of calcium in the control of cell reproduction. The role of calcium in biological systems. CRC Press, Boca Raton, Florida.
39. Mendels, J. Krajewski, T. F. Huffer, V. Taylor, R. J. Secunda, S. Schless, A. Sebastian, J. A. Semchshyn, G. Durr, M. J. Melmed, A. S. Whyte, A. (1986), Effective short-term treatment of generalized anxiety disorder with trifluoperazine. J. Clin. Psychiatry, 47, 170, 4.
40. Muallem, S. (1990), Calcium transport by resting and stimulated cells. Intracellular calcium regulation. 350, 71, Alan R. Liss, New York.
41. Netland, P. A. Chaturvedi, N. Dreyer, E. B. (1993), Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am. J. Ophthalmol. 115, 608, 13.
42. Nikkila, M. Inkovaara, J. Heikkinen, J. (1991), Once daily compared with twice daily administration of slow-release diltiazem as monotherapy for hypertension. Annals Med. 23, 141, 5.
43. Porchet, H. C. Dayer, P. (1990), Serum concentrations and effects of (±)-nicardipine compared with nifedipine in a population of healthy subjects. Clin. Pharmacol. 48, 155, 60.
44. Presta, M. Maier, J. A. Ragnotti, G. (1989), The mitogenic signalling pathway but not the plasminogen activator-inducing pathway of basic fibroblast growth factor is mediated through protein kinase C in fetal bovine aortic endothelial cells. J. Cell Biol. 109, 1877, 84.
45. Richter, D. Hatvani, I. Toth, A. (1993), Growth inhibition of intraocular proliferative explants under in vitro conditions by verapamil. Klinische Monatsblatter fur Augenheilkunde, 203, 206, 11.
46. Robertson, R. P. (1991), Harrison's principles of internal medicine. Wilson, J. D.Braunwald, E.Isselbacher, K. J.Petersdorf, R. G.Martin, J. B.Fauci, A. S.Root, R. K. 348, 53, McGraw-Hill, New York.
47. Rojanapongpun, P. Drance, S. M. (1993), The response of blood flow velocity in the ophthalmic artery and blood flow of the finger to warm and cold stimuli in glaucomatous patients. Graefes Arch. Clin. Exp. Ophthalmol. 231, 375, 7.
48. Schultz, P. J. Raij, L. (1990), Inhibition of human mesangial cell proliferation by calcium channel blockers. Hypertension, 15 (suppl), 76, 80.
49. Simonelli, P. Papa, A. Macciocchi, B. Auriemma, F. Vetrano, A. Scaletta Romeo di, Santillo, M. Ceriello, A. (1993), Treatment of ischemic disease in the elderly. Comparison of diltiazem, verapamil and gallopamil. Minerva Cardioangiologica, 41, 193, 204.
50. Skuta, G. L. Parrish, R. K. II, (1987), Wound healing in glaucoma filtering surgery. Surv. Ophthalmol. 32, 149.
51. Spedding, M. Paoletti, R. (1992), Classification of calcium channels and calcium antagonists: Progress report. Cardiovasc. Drugs Ther. 6, 35.
52. Sperti, G. Colucci, W. S. (1991), Calcium influx modulates DNA synthesis and proliferation in A7r5 vascular smooth muscle cells. Eur. J. Pharmacol. 206, 279, 84.
53. Steinleiter, A. Lambert, H. Kazensky, C. Sanchez, I. Sueldo, C. (1990), Reduction of primary postoperative adhesion formation under calcium channel blockade in the rabbit. J. Surg. Res. 48, 42, 5.
54. Tahery, M. M. Lee, D. A. (1989), Pharmacologic control of wound healing in glaucoma filtration surgery. J. Ocul. Pharmacol. 5, 155.
55. Waters, D. Lesperance, J. (1992), Interventions that beneficially influence the evolution of coronary atherosclerosis. The case for calcium channel blockers. Circulation, 86 (Suppl), 111, 6.
56. Williams, G. H. Dluhy, R. G. (1991), Growth Factors. Harrison's principles of internal medicine. Wilson, J. D.Braunwald, E.Isselbacher, K. J.Petersdorf, R. G.Martin, J. B.Fauci, A. S.Root, R. K.). 60, 4, McGraw-Hill, New York.
57. Witkowski, J. M. Siebert, J. Lukaszuk, K. Trawicka, L. (1993), Comparison of effect of a panel of membrane channel blockers on the proliferative, cytotoxic and cytoadherence abilities of human peripheral blood lymphocytes. Immunopharmacology, 26, 53, 63.
58. Yamada, Y. Furui, H. Furumichi, T. Suzuki, T. Yamauchi, K. Yokota, M. Hayashi, H. Saito, H. (1990), Inhibitory effects of endothelial cells and calcium channel blockers on platelet aggregation. Jpn. Heart J, 31, 201, 15.
59. 2+, Biokhimilia, 19, 299, 311.